Allergan Buys Esprit Pharma

Irvine-based Allergan said today that it has entered into an agreement to acquire Esprit Pharma, in a deal worth $370M. Esprit is a firm developing products for the genitourinary market, including compounds for treating urinary incontinence. The all-cash deal is expected to close in the fourth quarter. Esprit Pharma is headquartered in East Brunswick, New Jersey.